CDC approves Moderna, Pfizer-BioNTech Omicron booster shots for everyone 12 and older
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On September 5, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s (FDA) approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31. The boosters generate stronger immune protection against COVID-19 variants that are currently circulating widely in the U.S.
The updated emergency use authorizations permit the administration of a single booster at least two months after a primary or booster dose is given. The CDC Director, Dr. Rochelle Walensky, released a statement recommending eligibility for the Pfizer-BioNTech bivalent COVID-19 booster for people ages 12 and older and the Moderna COVID-19 booster for people ages 18 and older. The updated COVID-19 boosters add protection against the Omicron BA.4 and BA.5 variants, which currently make up nearly 90 percent of all cases of COVID-19 in the U.S. The CDC booster recommendation is for all individuals that have received at least a full primary vaccination series, which according to CDC guidance includes both a primary (2-dose) series and a one-dose booster.
The Biden administration has ordered 175 million doses of the new boosters. Pfizer plans to ship up to 15 million doses of its booster to the U.S. by September 9. Additionally, Pfizer plans to apply for an emergency use authorization for its booster to be used for children ages 5-11 in early October and is working to receive FDA approval for boosters for children under the age of 5.
The COVID-19 vaccines authorized for use in the U.S. continue to reduce the risk of severe disease, hospitalization and death, including against the Omicron variant and subvariants. As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported the administration of more than 610 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters.
ADDITIONAL RESOURCES
Resource
The County Role in Vaccines
Related News
U.S. House reintroduces legislation to address the Medicaid Inmate Exclusion Policy with NACo support
Two bipartisan bills aimed at addressing the Medicaid Inmate Exclusion Policy (MIEP) were recently reintroduced in the U.S. House of Representatives.
U.S. House of Representatives re-establishes Bipartisan Mental Health Caucus with NACo support
On May 7, members of the U.S. House of Representatives appointed new leadership to the Bipartisan Mental Health Caucus, reaffirming their commitment to addressing the nation’s mental health crisis through cross-party collaboration.
House passes SUPPORT Act reauthorization
On June 4, the U.S. House of Representatives passed the SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483) by a strong bipartisan vote of 366–57. The bill, which reauthorizes billions of dollars for critical programs that target overdose prevention, now heads to the Senate Committee on Health, Education, Labor and Pensions, where a version of the bill was overwhelmingly advanced with bipartisan support in the 118th Congress.